Sponsor or institution

Clinical trials and research at CSL Behring

• 15Clinical trials
• 40Countries

Newest trials

All recruiting trials (15)

• IgPro20 in adults with immune deficiencies after CAR T-cell or T-cell redirecting therapies

  This study tests IgPro20 in adults with secondary immune deficiency after CAR T-cell or T-cell redirecting therapies to see if it lowers serious bacterial infections.

  Recruiting at 2 sites Phase 3 CSL Behring · Orange, California and 59 other locations · NCT07648264

• CSL300 in Chinese adults with End Stage Kidney Disease on dialysis

  This study tests how CSL300 behaves in the body after single and multiple doses in Chinese adults with end stage kidney disease on dialysis, compared with placebo.

  Recruiting Phase 1 CSL Behring · Beijing · NCT07619820

• Testing CE1226 doses to slow lung disease in adults with alpha-1 antitrypsin deficiency

  This trial tests two active doses of CE1226 to see if they slow lung density decline in adults with AAT deficiency and emphysema over 3 years compared with the standard 60 mg/kg dose.

  Recruiting at 2 sites Phase 4 CSL Behring · Aalborg and 1 other locations · NCT07326592

• Testing Anumigilimab (CSL324) safety in adults with sickle cell disease

  This study will test whether subcutaneous Anumigilimab is safe for adults with sickle cell disease who had 1–12 painful vaso-occlusive crises in the past year.

  Recruiting at 38 sites Phase 2 CSL Behring · Little Rock, Arkansas and 37 other locations · NCT07224360

• Comparing 4F‑PCC (BE1116) and fresh frozen plasma to treat bleeding during complex heart surgery with cardiopulmonary bypass

  This trial tests whether BE1116 (a 4‑factor prothrombin complex concentrate) works better than fresh frozen plasma to correct clotting problems in adults who bleed during complex heart surgery with cardiopulmonary bypass.

  Recruiting at 15 sites Phase 3 CSL Behring · Los Angeles, California and 23 other locations · NCT07094087

• Single-dose CSL222 gene therapy for adolescent males (12–17) with severe or moderately severe hemophilia B.

  This will give a single dose of CSL222 gene therapy to adolescent males with severe or moderately severe hemophilia B to see if it raises factor IX activity and reduces bleeding.

  Recruiting at 17 sites Phase 3 CSL Behring · Orange, California and 16 other locations · NCT07080905

• Nebulized CSL787 (inhaled IgG) to reduce lung flare-ups in adults with non-cystic fibrosis bronchiectasis

  This research will test whether inhaled CSL787 (a nebulized immunoglobulin medicine) can delay or reduce lung flare-ups in adults with non-cystic fibrosis bronchiectasis over 6–12 months compared with placebo.

  Recruiting at 13 sites Phase 2 CSL Behring · Queensland and 12 other locations · NCT07048262

• Garadacimab to prevent hereditary angioedema attacks

  This study will test whether garadacimab is safe and reduces attack frequency for people aged 12 and older with hereditary angioedema who are starting the medication in routine care.

  Recruiting at 17 sites CSL Behring · Phoenix, Arizona and 21 other locations · NCT07001280

• Evaluating CSL889 for treating vaso-occlusive crises in sickle cell disease

  This study is testing a new treatment called CSL889 to see if it can help adults and teens with sickle cell disease who are having painful vaso-occlusive crises feel better.

  Recruiting at 28 sites Phase 2 CSL Behring · Oakland, California and 29 other locations · NCT06699849

• Using CSL511 to improve blood coagulation in patients with pseudomyxoma peritonei undergoing surgery

  This study is testing if a new treatment called CSL511 can help patients with pseudomyxoma peritonei manage bleeding better during surgery.

  Recruiting Phase 3 CSL Behring · Basingstoke · NCT06617897

• Observational study on the effectiveness and safety of HEMGENIX in hemophilia B patients

  This study is testing how well and safely HEMGENIX works for people with hemophilia B who are also getting Factor IX treatment.

  Recruiting at 12 sites CSL Behring · Rochester, New York and 11 other locations · NCT06008938

• Gene therapy for adults with Hemophilia B and specific antibodies

  This study is testing a new gene therapy called CSL222 to see if it can help adults with Hemophilia B who have certain antibodies reduce their bleeding risks.

  Recruiting at 32 sites Phase 3 CSL Behring · San Diego, California and 31 other locations · NCT06003387

• Testing CSL300 for heart health in dialysis patients with kidney disease

  This study is testing if a new treatment called CSL300 can improve heart health in dialysis patients with kidney disease and related conditions like diabetes or heart disease.

  Recruiting at 513 sites Phase 2/3 CSL Behring · Decatur, Alabama and 565 other locations · NCT05485961

• Using Hizentra® for treating Chronic Inflammatory Demyelinating Polyneuropathy

  This study is testing how well Hizentra® works for people with Chronic Inflammatory Demyelinating Polyneuropathy when switching from an IV treatment to a shot under the skin.

  Recruiting at 24 sites CSL Behring · Amiens and 26 other locations · NCT04672733

• Testing two doses of Privigen for children with CIDP

  This study is testing two different doses of Privigen to see if it helps children aged 2 to 17 with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

  Recruiting at 3 sites Phase 4 CSL Behring · Phoenix, Arizona and 8 other locations · NCT03684018

Quick answers

How many clinical trials run by CSL Behring are recruiting right now?

15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 40 countries. The most sites are in United States (9 trials), United Kingdom (7 trials), France (6 trials), Canada (5 trials), Turkey (Türkiye) (4 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 5, Phase 2: 3, Phase 4: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →